How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Buy
58
USFD Quote, Financials, Valuation and Earnings
Last price:
$63.27
Seasonality move
:
5.43%
Day range:
$61.65 - $63.45
52-week range:
$49.91 - $73.19
Dividend yield:
0%
P/E ratio:
30.27x
P/S ratio:
0.39x
P/B ratio:
3.11x
Volume:
1.4M
Avg. volume:
2.4M
1-year change:
22.2%
Market cap:
$14.1B
Revenue:
$37.9B
EPS (TTM):
$2.02
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $22.9B | $29.5B | $34.1B | $35.6B | $37.9B | |
| Revenue Growth (YoY) | -11.77% | 28.85% | 15.5% | 4.52% | 6.41% | |
| Cost of Revenues | $19.2B | $24.8B | $28.6B | $29.4B | $31.3B | |
| Gross Profit | $3.7B | $4.7B | $5.5B | $6.1B | $6.5B | |
| Gross Profit Margin | 16.25% | 15.79% | 16.13% | 17.27% | 17.25% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.8B | $4.2B | $4.9B | $5.1B | $5.4B | |
| Other Inc / (Exp) | -$18M | -$8M | $10M | -$29M | -$163M | |
| Operating Expenses | $3.8B | $4.2B | $4.9B | $5.1B | $5.4B | |
| Operating Income | -$38M | $435M | $606M | $1B | $1.1B | |
| Net Interest Expenses | $238M | $213M | $255M | $324M | $315M | |
| EBT. Incl. Unusual Items | -$294M | $214M | $361M | $678M | $644M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$68M | $50M | $96M | $172M | $150M | |
| Net Income to Company | -$226M | $164M | $265M | $506M | $494M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$226M | $164M | $265M | $506M | $494M | |
| Basic EPS (Cont. Ops) | -$1.15 | $0.55 | $1.02 | $2.09 | $2.05 | |
| Diluted EPS (Cont. Ops) | -$1.15 | $0.54 | $1.01 | $2.02 | $2.02 | |
| Weighted Average Basic Share | $220M | $222M | $224M | $239M | $241M | |
| Weighted Average Diluted Share | $220M | $225M | $226M | $250M | $244M | |
| EBITDA | $366M | $805M | $988M | $1.4B | $1.4B | |
| EBIT | -$56M | $427M | $616M | $1B | $959M | |
| Revenue (Reported) | $22.9B | $29.5B | $34.1B | $35.6B | $37.9B | |
| Operating Income (Reported) | -$38M | $435M | $606M | $1B | $1.1B | |
| Operating Income (Adjusted) | -$56M | $427M | $616M | $1B | $959M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.1B | $7.6B | $8.5B | $8.9B | $9.5B | |
| Revenue Growth (YoY) | -11.48% | 24.45% | 11.47% | 4.94% | 6.21% | |
| Cost of Revenues | $5.1B | $6.4B | $7.1B | $7.3B | $7.8B | |
| Gross Profit | $1B | $1.2B | $1.5B | $1.6B | $1.7B | |
| Gross Profit Margin | 16.42% | 16.26% | 17.08% | 17.79% | 17.55% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $978M | $1.1B | $1.2B | $1.3B | $1.4B | |
| Other Inc / (Exp) | $5M | $7M | -$6M | -$12M | -$137M | |
| Operating Expenses | $978M | $1.1B | $1.2B | $1.3B | $1.4B | |
| Operating Income | $30M | $137M | $208M | $292M | $304M | |
| Net Interest Expenses | $60M | $55M | $75M | $80M | $80M | |
| EBT. Incl. Unusual Items | -$25M | $89M | $127M | $200M | $87M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$15M | $20M | $34M | $53M | $21M | |
| Net Income to Company | -$10M | $69M | $93M | $147M | $66M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$10M | $69M | $93M | $147M | $66M | |
| Basic EPS (Cont. Ops) | -$0.10 | $0.26 | $0.37 | $0.60 | $0.28 | |
| Diluted EPS (Cont. Ops) | -$0.10 | $0.26 | $0.37 | $0.59 | $0.28 | |
| Weighted Average Basic Share | $220M | $222M | $224M | $245M | $232M | |
| Weighted Average Diluted Share | $220M | $225M | $226M | $247M | $235M | |
| EBITDA | $141M | $236M | $301M | $385M | $278M | |
| EBIT | $35M | $144M | $202M | $280M | $167M | |
| Revenue (Reported) | $6.1B | $7.6B | $8.5B | $8.9B | $9.5B | |
| Operating Income (Reported) | $30M | $137M | $208M | $292M | $304M | |
| Operating Income (Adjusted) | $35M | $144M | $202M | $280M | $167M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $22.9B | $29.5B | $34.1B | $35.6B | $37.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $19.2B | $24.8B | $28.6B | $29.4B | $31.3B | |
| Gross Profit | $3.7B | $4.7B | $5.5B | $6.1B | $6.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.8B | $4.2B | $4.9B | $5.1B | $5.4B | |
| Other Inc / (Exp) | -$18M | -$8M | $10M | -$29M | -$163M | |
| Operating Expenses | $3.8B | $4.2B | $4.9B | $5.1B | $5.4B | |
| Operating Income | -$38M | $435M | $606M | $1B | $1.1B | |
| Net Interest Expenses | $238M | $213M | $255M | $324M | $315M | |
| EBT. Incl. Unusual Items | -$294M | $214M | $361M | $678M | $644M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$68M | $50M | $96M | $172M | $150M | |
| Net Income to Company | -$226M | $164M | $265M | $506M | $494M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$226M | $164M | $265M | $506M | $494M | |
| Basic EPS (Cont. Ops) | -$1.15 | $0.54 | $1.01 | $2.07 | $2.03 | |
| Diluted EPS (Cont. Ops) | -$1.15 | $0.52 | $1.00 | $2.02 | $2.02 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $366M | $805M | $988M | $1.4B | $1.4B | |
| EBIT | -$56M | $427M | $616M | $1B | $959M | |
| Revenue (Reported) | $22.9B | $29.5B | $34.1B | $35.6B | $37.9B | |
| Operating Income (Reported) | -$38M | $435M | $606M | $1B | $1.1B | |
| Operating Income (Adjusted) | -$56M | $427M | $616M | $1B | $959M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $29.5B | $34.1B | $35.6B | $37.9B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $24.8B | $28.6B | $29.4B | $31.3B | -- | |
| Gross Profit | $4.7B | $5.5B | $6.1B | $6.5B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.2B | $4.9B | $5.1B | $5.4B | -- | |
| Other Inc / (Exp) | -$8M | $10M | -$29M | -$163M | -- | |
| Operating Expenses | $4.2B | $4.9B | $5.1B | $5.4B | -- | |
| Operating Income | $435M | $606M | $1B | $1.1B | -- | |
| Net Interest Expenses | $213M | $255M | $324M | $315M | -- | |
| EBT. Incl. Unusual Items | $214M | $361M | $678M | $644M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $50M | $96M | $172M | $150M | -- | |
| Net Income to Company | $164M | $265M | $506M | $494M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $164M | $265M | $506M | $494M | -- | |
| Basic EPS (Cont. Ops) | $0.54 | $1.01 | $2.07 | $2.03 | -- | |
| Diluted EPS (Cont. Ops) | $0.52 | $1.00 | $2.02 | $2.02 | -- | |
| Weighted Average Basic Share | $887M | $896M | $956M | $964M | -- | |
| Weighted Average Diluted Share | $896M | $926M | $999M | $975M | -- | |
| EBITDA | $805M | $988M | $1.4B | $1.4B | -- | |
| EBIT | $427M | $616M | $1B | $959M | -- | |
| Revenue (Reported) | $29.5B | $34.1B | $35.6B | $37.9B | -- | |
| Operating Income (Reported) | $435M | $606M | $1B | $1.1B | -- | |
| Operating Income (Adjusted) | $427M | $616M | $1B | $959M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $828M | $148M | $211M | $269M | $59M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.1B | $1.5B | $1.7B | $1.9B | $2B | |
| Inventory | $1.3B | $1.7B | $1.6B | $1.6B | $1.6B | |
| Prepaid Expenses | $132M | $120M | $124M | $138M | $146M | |
| Other Current Assets | $26M | $18M | $19M | $14M | $11M | |
| Total Current Assets | $3.5B | $3.6B | $3.8B | $4B | $4B | |
| Property Plant And Equipment | $2B | $2B | $2.2B | $2.3B | $2.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $5.6B | $5.6B | $5.6B | $5.7B | $5.8B | |
| Other Intangibles | $892M | $830M | $785M | $803M | $836M | |
| Other Long-Term Assets | $407M | $431M | $372M | $376M | $462M | |
| Total Assets | $12.4B | $12.5B | $12.8B | $13.2B | $13.4B | |
| Accounts Payable | $1.2B | $1.7B | $1.9B | $2.1B | $2.2B | |
| Accrued Expenses | $276M | $388M | $456M | $481M | $489M | |
| Current Portion Of Long-Term Debt | $131M | $95M | $116M | $110M | $109M | |
| Current Portion Of Capital Lease Obligations | $44M | $36M | $36M | $43M | $42M | |
| Other Current Liabilities | $90M | $98M | $68M | $91M | $73M | |
| Total Current Liabilities | $2B | $2.6B | $2.8B | $3.1B | $3.3B | |
| Long-Term Debt | $5.6B | $4.9B | $4.7B | $4.6B | $4.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $8.4B | $8.3B | $8.3B | $8.4B | $8.9B | |
| Common Stock | $521M | $536M | $536M | $3M | $3M | |
| Other Common Equity Adj | -$34M | -$19M | -$73M | -$115M | $43M | |
| Common Equity | $3.5B | $3.7B | $4B | $4.7B | $4.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4B | $4.3B | $4.5B | $4.7B | $4.5B | |
| Total Liabilities and Equity | $12.4B | $12.5B | $12.8B | $13.2B | $13.4B | |
| Cash and Short Terms | $828M | $148M | $211M | $269M | $59M | |
| Total Debt | $5.9B | $5.2B | $5B | $4.9B | $5.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $828M | $148M | $211M | $269M | $59M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.1B | $1.5B | $1.7B | $1.9B | $2B | |
| Inventory | $1.3B | $1.7B | $1.6B | $1.6B | $1.6B | |
| Prepaid Expenses | $132M | $120M | $124M | $138M | $146M | |
| Other Current Assets | $26M | $18M | $19M | $14M | $11M | |
| Total Current Assets | $3.5B | $3.6B | $3.8B | $4B | $4B | |
| Property Plant And Equipment | $2B | $2B | $2.2B | $2.3B | $2.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $5.6B | $5.6B | $5.6B | $5.7B | $5.8B | |
| Other Intangibles | $892M | $830M | $785M | $803M | $836M | |
| Other Long-Term Assets | $407M | $431M | $372M | $376M | $462M | |
| Total Assets | $12.4B | $12.5B | $12.8B | $13.2B | $13.4B | |
| Accounts Payable | $1.2B | $1.7B | $1.9B | $2.1B | $2.2B | |
| Accrued Expenses | $276M | $388M | $456M | $481M | $489M | |
| Current Portion Of Long-Term Debt | $131M | $95M | $116M | $110M | $109M | |
| Current Portion Of Capital Lease Obligations | $44M | $36M | $36M | $43M | $42M | |
| Other Current Liabilities | $90M | $98M | $68M | $91M | $73M | |
| Total Current Liabilities | $2B | $2.6B | $2.8B | $3.1B | $3.3B | |
| Long-Term Debt | $5.6B | $4.9B | $4.7B | $4.6B | $4.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $8.4B | $8.3B | $8.3B | $8.4B | $8.9B | |
| Common Stock | $521M | $536M | $536M | $3M | $3M | |
| Other Common Equity Adj | -$34M | -$19M | -$73M | -$115M | $43M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4B | $4.3B | $4.5B | $4.7B | $4.5B | |
| Total Liabilities and Equity | $12.4B | $12.5B | $12.8B | $13.2B | $13.4B | |
| Cash and Short Terms | $828M | $148M | $211M | $269M | $59M | |
| Total Debt | $5.9B | $5.2B | $5B | $4.9B | $5.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$226M | $164M | $265M | $506M | $494M | |
| Depreciation & Amoritzation | $422M | $378M | $372M | $395M | $438M | |
| Stock-Based Compensation | $40M | $48M | $45M | $56M | $63M | |
| Change in Accounts Receivable | $334M | -$386M | -$240M | -$157M | -$140M | |
| Change in Inventories | $201M | -$413M | $70M | $61M | -$16M | |
| Cash From Operations | $413M | $419M | $765M | $1.1B | $1.2B | |
| Capital Expenditures | $189M | $274M | $265M | $309M | $341M | |
| Cash Acquisitions | -$972M | -- | -- | -$196M | -$214M | |
| Cash From Investing | -$1.1B | -$262M | -$255M | -$495M | -$552M | |
| Dividends Paid (Ex Special Dividend) | -- | -$28M | -$37M | -$7M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.6B | $2.3B | $1.2B | $1.5B | $6.1B | |
| Long-Term Debt Repaid | -$2.7B | -$3.1B | -$1.6B | -$1.8B | -$6B | |
| Repurchase of Common Stock | -- | -- | -$14M | -$294M | -$948M | |
| Other Financing Activities | -$38M | -$44M | -$20M | -$26M | -$34M | |
| Cash From Financing | $1.4B | -$837M | -$447M | -$587M | -$831M | |
| Beginning Cash (CF) | $98M | $828M | $148M | $211M | $269M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $730M | -$680M | $63M | $58M | -$209M | |
| Ending Cash (CF) | $828M | $148M | $211M | $269M | $60M | |
| Levered Free Cash Flow | $224M | $145M | $500M | $831M | $833M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10M | $69M | $93M | $147M | $66M | |
| Depreciation & Amoritzation | $106M | $92M | $99M | $105M | $111M | |
| Stock-Based Compensation | $11M | $12M | $11M | $13M | $17M | |
| Change in Accounts Receivable | $152M | $144M | $195M | $134M | $142M | |
| Change in Inventories | $40M | -$121M | $144M | $16M | -$10M | |
| Cash From Operations | -$120M | -$101M | $152M | $205M | $283M | |
| Capital Expenditures | $35M | $101M | $64M | $142M | $105M | |
| Cash Acquisitions | $1M | -- | -- | -$54M | -- | |
| Cash From Investing | -$23M | -$96M | -$58M | -$194M | -$105M | |
| Dividends Paid (Ex Special Dividend) | -- | -$10M | -$10M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1.4B | $176M | $201M | $3.7B | |
| Long-Term Debt Repaid | -$52M | -$1.8B | -$405M | -$231M | -$3.5B | |
| Repurchase of Common Stock | -- | -- | -$14M | -$65M | -$320M | |
| Other Financing Activities | -- | -$13M | -$4M | -$1M | -$13M | |
| Cash From Financing | -$48M | -$426M | -$249M | -$88M | -$199M | |
| Beginning Cash (CF) | $1B | $772M | $366M | $346M | $81M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$191M | -$623M | -$155M | -$77M | -$21M | |
| Ending Cash (CF) | $828M | $148M | $211M | $269M | $60M | |
| Levered Free Cash Flow | -$155M | -$202M | $88M | $63M | $178M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$226M | $164M | $265M | $506M | $494M | |
| Depreciation & Amoritzation | $422M | $378M | $372M | $395M | $438M | |
| Stock-Based Compensation | $40M | $48M | $45M | $56M | $63M | |
| Change in Accounts Receivable | $334M | -$386M | -$240M | -$157M | -$140M | |
| Change in Inventories | $201M | -$413M | $70M | $61M | -$16M | |
| Cash From Operations | $413M | $419M | $765M | $1.1B | $1.2B | |
| Capital Expenditures | $189M | $274M | $265M | $309M | $341M | |
| Cash Acquisitions | -$972M | -- | -- | -$196M | -$214M | |
| Cash From Investing | -$1.1B | -$262M | -$255M | -$495M | -$552M | |
| Dividends Paid (Ex Special Dividend) | -- | -$28M | -$37M | -$7M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.6B | $2.3B | $1.2B | $1.5B | $6.1B | |
| Long-Term Debt Repaid | -$2.7B | -$3.1B | -$1.6B | -$1.8B | -$6B | |
| Repurchase of Common Stock | -- | -- | -$14M | -$294M | -$948M | |
| Other Financing Activities | -$38M | -$44M | -$20M | -$26M | -$34M | |
| Cash From Financing | $1.4B | -$837M | -$447M | -$587M | -$831M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $730M | -$680M | $63M | $58M | -$209M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $224M | $145M | $500M | $831M | $833M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $164M | $265M | $506M | $494M | -- | |
| Depreciation & Amoritzation | $378M | $372M | $395M | $438M | -- | |
| Stock-Based Compensation | $48M | $45M | $56M | $63M | -- | |
| Change in Accounts Receivable | -$386M | -$240M | -$157M | -$140M | -- | |
| Change in Inventories | -$413M | $70M | $61M | -$16M | -- | |
| Cash From Operations | $419M | $765M | $1.1B | $1.2B | -- | |
| Capital Expenditures | $274M | $265M | $309M | $341M | -- | |
| Cash Acquisitions | -- | -- | -$196M | -$214M | -- | |
| Cash From Investing | -$262M | -$255M | -$495M | -$552M | -- | |
| Dividends Paid (Ex Special Dividend) | -$28M | -$37M | -$7M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.3B | $1.2B | $1.5B | $6.1B | -- | |
| Long-Term Debt Repaid | -$3.1B | -$1.6B | -$1.8B | -$6B | -- | |
| Repurchase of Common Stock | -- | -$14M | -$294M | -$948M | -- | |
| Other Financing Activities | -$44M | -$20M | -$26M | -$34M | -- | |
| Cash From Financing | -$837M | -$447M | -$587M | -$831M | -- | |
| Beginning Cash (CF) | $3.2B | $901M | $1.2B | $1B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$680M | $63M | $58M | -$209M | -- | |
| Ending Cash (CF) | $2.5B | $964M | $1.3B | $813M | -- | |
| Levered Free Cash Flow | $145M | $500M | $831M | $833M | -- | |
Get USFD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
USFD
Sector
P/E ratio
30.27x
18.23x
PEG ratio
1.04x
0.28x
P/B ratio
3.11x
1.58x
Price / LTM sales
0.39x
0.60x
Growth Metrics
USFD
Sector
Revenue growth
6.21%
2.13%
Earnings growth
-52.54%
4.62%
Revenue (5-year growth)
7.87%
4.1%
Earnings forecast
$0.70
$0.31
Profitability
USFD
Sector
Profitability FY 2024
$6.5B
$541.6M
Return on invested capital
5.09%
5.48%
Return on assets
3.68%
3.56%
Return on equity
10.41%
8.28%
Earnings Date
Last Earnings Date
Feb
13
Next Earnings Date
May
8
Estimated Next Earnings Date
May
15
Balance Sheet
USFD
Sector
Total cash
$59M
$149.2M
Short term investments
--
$41.9M
Total assets
$13.4B
$1.8B
Long term debt
$5.1B
$220M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
61
AGX alert for Apr 23
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
